A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma: Japan Clinical Oncology Group Study 9002

2004 ◽  
Vol 80 (4) ◽  
pp. 341-350 ◽  
Author(s):  
Tomohiro Kinoshita ◽  
Tomomitsu Hotta ◽  
Kensei Tobinai ◽  
Tohru Kobayashi ◽  
Naoki Ishizuka ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document